Ritedose Now Offers the Largest Nebulized Drug Portfolio in the U.S.: FDA Approves the Company to Manufacture Generic Tobramycin Inhalation Solution

Ritedose receives FDA approval for Tobramycin Tobramycin expands nation's largest nebulized drug portfolio. - Generic Tobramycin Inhalation Solution marks the first cystic fibrosis (CF) product in the ...
The Bakersfield Californian

Ritedose Now Offers the Largest Nebulized Drug Portfolio in the U.S.: FDA Approves the Company ...

Generic Tobramycin Inhalation Solution marks the first cystic fibrosis (CF) product in the Company’s portfolio ...
SiliconIndia

Key Features to Consider in the Best Nebulizer Machine in India

Key Features to Consider in the Best Nebulizer Machine in India - Have you ever bought a health device that ended up ...

United States Nebulizer Market Research 2025-2033, Competitive Analysis of OMRON, GE Healthcare, Boston Scientific, Koninklijke Philips, Vectura, Aerogen, DeVilbiss Healthcare ...

The United States nebulizer market is set to grow from US$ 466.55 million in 2024 to US$ 730.62 million by 2033, with a CAGR of 5.11%. This growth is driven by the rising prevalence of respiratory ...
Taiwan News

Liquidia Corporation to Report Third Quarter 2025 Financial Results on November 3, 2025

About Liquidia Corporation Liquidia Corporation is a biopharmaceutical company developing innovative therapies for patients with rare cardiopulmonary disease. The company’s current focus spans the ...
Northwest Georgia News

Breathe Easy This Fall: VARON Supports Respiratory Wellness During Seasonal Change

As cooler temperatures and shifting air quality arrive, many families notice changes in their breathing. Dry air, allergens, ...